| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |